Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.

Source:http://linkedlifedata.com/resource/pubmed/id/3005399

J. Immunol. 1986 Mar 1 136 5 1700-7

Download in:

View as

General Info

PMID
3005399